SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000950159-14-000074
Filing Date
2014-02-13
Accepted
2014-02-13 13:58:14
Documents
1
Group Members
QUAKER BIOVENTURES CAPITAL II L.P.QUAKER BIOVENTURES CAPITAL II LLC

Document Format Files

Seq Description Document Type Size
1 QUAKER BIOVENTURES II, L.P. FORM SC 13G transenterix13g.htm SC 13G 116841
  Complete submission text file 0000950159-14-000074.txt   118696
Mailing Address 635 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560
Business Address 635 DAVIS DRIVE SUITE 300 MORRISVILLE NC 27560 919-765-8400
TRANSENTERIX INC. (Subject) CIK: 0000876378 (see all company filings)

IRS No.: 112962080 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-42262 | Film No.: 14604928
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Filed by) CIK: 0001497725 (see all company filings)

IRS No.: 205328033 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G